You have 9 free searches left this month | for more free features.

City

Nanjing (1)

Nanning (1)

Condition

Diabetic Nephropathies (1)

Magnetic Resonance Imaging (1)

Mild Cognitive Impairment (1)

Myocardial Fibrosis (1)

Obesity (1)

Sodium-glucose Co-transporter-2 Inhibitor (1)

Type 2 Diabetes (1)

Type 2 Diabetes Mellitus (1)

Type2diabetes (1)

Overall Status

Not yet recruiting (3)

Recruiting (1)

Sign in for free

Phase

n/a (3)

phase 4 (1)

Sponsor

First Affiliated Hospital of Guangxi Medical University (1)

Qianfoshan Hospital (1)

RenJi Hospital (1)

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Collaborator

Intervention

henagliflozin (4)

continuous subcutaneous insulin infusion (1)

gliclazide (1)

metformin (1)

placebo (1)

Study Documents

Intervention Type

drug (4)

device (1)

Funder Type

Other (4)

Study Type

Interventional (4)

henagliflozin

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Diabetic Nephropathies Trial (Henagliflozin, Placebo)

Not yet recruiting

Diabetic Nephropathies

Henagliflozin
Placebo

(no location specified)

Sep 3, 2023

Obesity, Type 2 Diabetes, Sodium-glucose Co-transporter-2 Inhibitor Trial (Henagliflozin, Metformin)

Not yet recruiting

Obesity
+4 more

Henagliflozin
Metformin

(no location specified)

Sep 27, 2023

Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Henagliflozin, Gliclazide)

Recruiting

Type 2 Diabetes Mellitus
Mild Cognitive Impairment

Henagliflozin
Gliclazide

Nanjing, Jiangsu, China

Division of Endocrinology, the Affiliated Drum Tower Hospital of

Oct 10, 2023

Type2diabetes Trial in Nanning (Henagliflozin, Continuous Subcutaneous Insulin Infusion)

Not yet recruiting

Type2diabetes

Henagliflozin
Continuous Subcutaneous Insulin Infusion

Nanning, Guangxi, China

First Affiliated Hospital of Guangxi Medical University

Jan 9, 2023